688578.SH
艾力斯
SSE · Healthcare · Biotechnology · CN
CNY 112.19
−3.70%Aug 19, 2026, 08:39 UTC
Ailisi announced a cash dividend of 6.00 yuan per 10 shares, totaling 270 million yuan, for the first half of 2026.
Aug 18, 2026, 19:54 UTC
Allist Pharmaceuticals forecast first-half 2026 revenue of 3.31 billion yuan and net profit of 1.54 billion yuan, up 39.44% and 46.49% year-on-year respectively, driven by furmonertinib sales.
Aug 18, 2026, 04:14 UTC
Xiangya Second Hospital suspended procurement and use of Allist's furmonertinib mesylate tablets and three other drugs for three months starting August 17, 2026, due to unauthorized visits by pharmaceutical representatives.
Source: